These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18359165)

  • 1. Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state.
    Niikura K; Narita M; Narita M; Nakamura A; Okutsu D; Ozeki A; Kurahashi K; Kobayashi Y; Suzuki M; Suzuki T
    Neurosci Lett; 2008 Apr; 435(3):257-62. PubMed ID: 18359165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine.
    Narita M; Nakamura A; Ozaki M; Imai S; Miyoshi K; Suzuki M; Suzuki T
    Neuropsychopharmacology; 2008 Apr; 33(5):1097-112. PubMed ID: 17593930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area.
    Ozaki S; Narita M; Narita M; Iino M; Sugita J; Matsumura Y; Suzuki T
    J Neurochem; 2002 Sep; 82(5):1192-8. PubMed ID: 12358766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala.
    Narita M; Kaneko C; Miyoshi K; Nagumo Y; Kuzumaki N; Nakajima M; Nanjo K; Matsuzawa K; Yamazaki M; Suzuki T
    Neuropsychopharmacology; 2006 Apr; 31(4):739-50. PubMed ID: 16123756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
    Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
    Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
    Narita M; Miyoshi K; Narita M; Suzuki T
    Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA; Navani DM; Yoburn BC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
    Narita M; Matsushima Y; Niikura K; Narita M; Takagi S; Nakahara K; Kurahashi K; Abe M; Saeki M; Asato M; Imai S; Ikeda K; Kuzumaki N; Suzuki T
    Addict Biol; 2010 Oct; 15(4):434-47. PubMed ID: 20731628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of endogenous beta-endorphin in the inhibition of the morphine-induced rewarding effect by the direct activation of spinal protein kinase C in mice.
    Niikura K; Narita M; Okutsu D; Tsurukawa Y; Nanjo K; Kurahashi K; Kobayashi Y; Suzuki T
    Neurosci Lett; 2008 Mar; 433(1):54-8. PubMed ID: 18262361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
    Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
    Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.
    Narita M; Suzuki M; Imai S; Narita M; Ozaki S; Kishimoto Y; Oe K; Yajima Y; Yamazaki M; Suzuki T
    Life Sci; 2004 Apr; 74(21):2655-73. PubMed ID: 15041447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
    Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF
    Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.
    Petraschka M; Li S; Gilbert TL; Westenbroek RE; Bruchas MR; Schreiber S; Lowe J; Low MJ; Pintar JE; Chavkin C
    Neuroscience; 2007 Jun; 146(4):1795-807. PubMed ID: 17467916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.
    Alt A; Mansour A; Akil H; Medzihradsky F; Traynor JR; Woods JH
    J Pharmacol Exp Ther; 1998 Jul; 286(1):282-8. PubMed ID: 9655870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
    David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
    Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-opioid receptors are involved in the tolerance to nicotine antinociception.
    Galeote L; Kieffer BL; Maldonado R; Berrendero F
    J Neurochem; 2006 Apr; 97(2):416-23. PubMed ID: 16539669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Cancer Pain and Medical Narcotics].
    Suzuki T
    Yakugaku Zasshi; 2015; 135(12):1325-34. PubMed ID: 26632147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of spinal protein kinase C in the suppression of morphine-induced rewarding effect under a neuropathic pain-like state in mice.
    Narita M; Oe K; Kato H; Shibasaki M; Narita M; Yajima Y; Yamazaki M; Suzuki T
    Neuroscience; 2004; 125(3):545-51. PubMed ID: 15099668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation.
    Ozaki S; Narita M; Narita M; Ozaki M; Khotib J; Suzuki T
    J Neurochem; 2004 Mar; 88(6):1389-97. PubMed ID: 15009639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.